Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
HR 676, PATH/21st Century Cures Act, HEAL, S 31 Medicare RX program, Zadroga 9/11 health bill, Extend the least developed country designation under USTR rules, lobbying to adopt new rules related to NIH patents and licenses, access to medicines.
Medicare Prescription Drug Price Negotiation Act of 2015
Client: PUBLIC CITIZEN · Firm: PUBLIC CITIZEN
HR 676, PATH/21st Century Cures Act, HEAL, S 31 Medicare RX program, Zadroga 9/11 health bill, Extend the least developed country designation under USTR rules, lobbying to adopt new rules related to NIH patents and licenses, access to medicines.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PUBLIC CITIZEN via PUBLIC CITIZEN
2015 · third_quarter · Q3
Strong Act
HR 676, PATH/21st Century Cures Act, HEAL, S 31 Medicare RX program, Zadroga 9/11 health bill, Extend the least developed country designation under USTR rules, lobbying to adopt new rules related to NIH patents and licenses, access to medicines.
Source: Senate LDA
Fast Track, TPP
Filing targets: Consumer Financial Protection Bureau (CFPB), Environmental Protection Agency (EPA), Federal Deposit Insurance Corporation (FDIC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Securities & Exchange Commission (SEC), White House Office